According to a 2021 study, after a diagnosis of brain stem glioma, the average survival rate is around 24 months. This average survival time mostly relates to children between the ages of 5 and 9.

Gliomas are among the deadliest brain tumors, with limited treatment options and poor survival rates. Scientists from China identified FAM111B, a DNA-repair-associated protein, as a key driver of ...

The dual IDH1–IDH2 inhibitor vorasidenib more than doubled time to progression (relative to placebo) and thus represents the first new treatment in decades for patients with glioma.